Skip to content

Review, 2004

Could a brain hormone called allopregnanolone explain mood problems like PMDD in women?

This review suggests that changes in allopregnanolone, a hormone-like substance in the brain, may be linked to mood problems including premenstrual dysphoria (PMDD), but this is a theory based on existing animal and human research, not new proof.

Early or limited evidence Women in general; underlying research reviewed is mostly from animal models

What they did

A review of research, mostly in animal models, looking at how levels of the neurosteroid allopregnanolone change with the hormone cycle and how it affects stress, anxiety, depression, aggression, sleep, memory, pain and appetite.

What they found

In animal models, allopregnanolone levels change across the cycle and affect behavior and stress responses. The authors propose that unusual (increased, decreased, or irregular) allopregnanolone levels may play a role in depression, PMDD, anorexia and bulimia nervosa, and Alzheimer's disease, and that women may be especially sensitive to these hormone-related mood changes.

What it means for you

This points to a possible biological reason some women are more vulnerable to mood problems around their cycle, but it is a hypothesis built on a review of mostly animal studies, not a human trial, so it cannot prove cause and effect.

About the study

Original title
Disadaptive disorders in women: allopregnanolone, a sensitive steroid
Authors
Bernardi F, Pluchino N, Begliuomini S et al.
Journal
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Year
2004
Study design
Review
What was tested
None tested; the paper reviews the biology of the hormone allopregnanolone

Topics